StockWatch
·
Medical/Nursing Services
Quarterly ResultAug 5, 2026, 04:23 PM

Pennant Q2 Revenue $298.0M, Adj. EPS $0.36; Raises 2026 Guidance

AI Summary

Pennant Group reported strong second-quarter 2026 financial results, with total revenue increasing 35.8% year-over-year to $298.0 million. GAAP diluted earnings per share was $0.25, and adjusted diluted EPS reached $0.36. Net income grew 28.2% to $9.1 million, while adjusted net income increased 36.5% to $12.8 million. The company also updated its full-year 2026 guidance, anticipating total revenue between $1,171.1 million and $1,190.1 million, and adjusted diluted EPS between $1.34 and $1.41. An updated investor presentation will be posted on its website.

Key Highlights

  • Q2 2026 total revenue increased 35.8% to $298.0 million.
  • Q2 2026 GAAP diluted EPS was $0.25, and adjusted diluted EPS was $0.36.
  • Q2 2026 net income rose 28.2% to $9.1 million; adjusted net income increased 36.5% to $12.8 million.
  • Consolidated Adjusted EBITDA for Q2 2026 grew 48.2% to $24.3 million.
  • Home Health and Hospice Services segment revenue increased 43.2% to $237.8 million.
  • Senior Living Services segment revenue grew 12.6% to $60.2 million.
  • Updated 2026 annual revenue guidance is $1,171.1 million to $1,190.1 million.
  • Updated 2026 adjusted diluted EPS guidance is $1.34 to $1.41.